OncoHost Develops Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients
OncoHost developed a novel computational model for predicting significant immune-related adverse events in NSCLC patients.
Read More
Search Results for: lung cancer
Blood Test Detects Tumors Early in Families with Cancer
Researchers detected cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with a high risk of developing cancer.
Read More
Volition Presents New Liquid Biopsy Method for Early-Stage Cancer
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read More
Personalis’ MRD Assay Detects ctDNA in Lung Cancer Patients Earlier
NeXT Personal ctDNA assay shown to be more sensitive and predictive of clinical outcomes in early-stage lung cancer patients
Read More
Thermo Fisher and Boehringer Ingelheim Sign CDx Agreement to Select NSCLC Patients for Targeted Therapy
Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients.
Read More